European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - rotavirus vaccine 1e+006 ccid50 (rix4414 strain, grown in vero cells) - powder with diluent for oral suspension - 1e+006 ccid50 - active: rotavirus vaccine 1e+006 ccid50 (rix4414 strain, grown in vero cells) excipient: amino acids dextran 40 dulbecco's modified eagle medium sorbitol sucrose calcium carbonate water for injection xanthan gum - rotarix is indicated for the prevention of rotavirus gastroenteritis

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - virus polio type 1, strain lsc, 2ab; virus polio type 3, strain leon 12a, 1b - suspension - virus polio type 1, strain lsc, 2ab ≥10⁶·˚ccid₅₀; virus polio type 3, strain leon 12a, 1b ≥10⁵·⁸ccid₅₀

Bangladesh - English - DGDA (Directorate General of Drug Administration)

glaxosmithkline bangladesh ltd. - albendazole - tablet - 400 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

glaxosmithkline bangladesh ltd. - amoxicillin - capsule - 250 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

glaxosmithkline bangladesh ltd. - caffeine + paracetamol - tablet - 65 mg + 500 mg